Deliver logo

About ATMP Beijing Forum 2025

The Advanced Therapy Medicinal Products ( Beijing ) Forum -- Global Gene & Cellular Immunotherapy Innovators Beijing Forum 2025 will bring in fresh perspectives and establish an efficient platform for Academia & Industry to discuss about the Current and Future Perspectives of Advanced Therapy Medicinal Products ( ATMPs ), Promoting China Innovation and Strengthening Collaboration in the Advanced Therapies and Regenerative Medicine Space.

Brainstorm with over 100+ high caliber speakers and estimation to bring over 500+ Industry Stakeholders, Entrepreneurs, Cell and Gene Therapy Pioneers, Influencers and Pharma R&D professionals. With this in mind, The Themes of "Advanced Therapy Medicinal Products ( Beijing ) Forum -- Global Gene & Cellular Immunotherapy Innovators Beijing Forum 2025" will cover...
Learn more >>
Faculty Speaker Series
Carl H. June
Richard W. Vague Professor, Immunotherapy Director, Center for Cellular Immunotherapies Director, Parker Institute for Cancer Immunotherapy
University of Pennsylvania; Perelman School of Medicine
Bruce Levine
Barbara and Edward Netter Professor in Cancer Gene Therapy, Abramson Cancer Center
University of Pennsylvania, Perelman School of Medicine
Stephan Grupp
Section Chief, Cellular Therapy and Transplant, Division of Oncology
Children's Hospital of Philadelphia
Peter Marks
Director, Center for Biologics Evaluation and Research
U.S. Food and Drug Administration
Georg A. Schett
Professor of Internal Medicine
Head of Department
Department of Medicine 3 - Rheumatology and Immunology
Friedrich-Alexander-Universität Erlangen-Nürnberg
Germany
Hongjun Song
Perelman Professor of Neuroscience
University of Pennsylvania
Mitchell Ho
Senior Investigator Head, Antibody Therapy Section Deputy Chief, Laboratory of Molecular Biology Director, Antibody Engineering Program
National Cancer Institute, NIH
Jing-Wei Xiong
Professor (with tenure)
Peking University and Nanchang University
Renier Brentjens
Deputy Director and Chair of Medicine
Roswell Park Comprehensive Cancer Center
Eric Smith
Director of Translational Research, Immune Effector Cell Therapies
Dana-Farber Cancer Institute
Dan S. Kaufman
Professor
Dept. of Medicine
Director of Cell Therapy Program
UC- San Diego
Alex Matter
Senior Fellow
Agency for Science, Technology and Research (A*STAR), Singapore
Travis Young
Vice President, Biologics
Calibr, a division of Scripps Research
Xiuyan Wang
Director, Cell Therapy and Cell Engineering Facility
Memorial Sloan Kettering Cancer Center
Mickey Koh
Head of Haematology and Clinical Director - Renal, Haematology and Oncology
St George’s University Hospitals, London
Steve Oh
Director, Stem Cell Bioprocessing Group
A*STAR’s Bioprocessing Technology Institute
Yoji Sato
Head, Division of Cell-Based Therapeutic Products
National Institute of Health Sciences, Japan
Michael Milone
Associate Professor of Pathology and Laboratory Medicine
Perelman School of Medicine, University of Pennsylvania.
Rafal Krol
Principal Investigator, Research and Development Center
Kyoto University, CiRA Foundation
Hao Shen
President
Biosyngen
Xingrong Chen
Chief Executive Officer
Fosun Kairos
Yu Wang
Founder and CEO
Immunotech Biopharm
Wenshi Wang
SVP, Tech & Ops
Fosun Kairos
Tony Liu
Chairman and CEO
AbelZeta
Biao Zheng
Chief Executive Officer
BRL Medicine
Jian Hua
Managing Director
Shanghai Pharma Biotherapeutics
Zonghai Li
CEO & CSO
CARsgen Therapeutics
Hequn Yin
Senior Vice President, Research
Iovance Biotherapeutics
Huajun Jin
Founder, CEO and CTO
Juncell Therapeutics
Max Qian
Co-Founder and CEO
RUI Therapeutics
Shuang Mei
Chief Technology Officer
Imbioray
Alvin Luk
Co-Founder and CEO
HuidaGene Therapeutics
Lifan Wei
Director, Gene Editing Technology Development Institute
CSPC Pharmaceutical Group
Yugang Guo
Chief Executive Officer
Leman Biotech
Jianghua Wang
Chief Scientific Officer
Corregene Biotechnology
Candice Liew
Senior Director
Head of R&D
ReproGenix
Luke Li
Chief Executive Officer
Neurophth Therapeutics
Tao Yu
Vice President of R&D
GenAns Biotech
Liping Yang
Founder and CSO
Chinagenovo
Riguo Fang
Chief Executive Officer
Moucellion Therapeutics
Zibing Jin
Professor of Ophthalmology
Vice President
Beijing Tongren Hospital, CMU
Yangfei Xiang
Assistant Professor & Principle Investigator
School of Life Science and Technology
ShanghaiTech University
Zhen-Ge Luo
Professor and Executive Dean
School of Life Science and Technology
ShanghaiTech University
Peng Liu
Professor, Department of Biomedical Engineering
Tsinghua University
Aimin Hui
Founder, Chair and CEO
EnCureGen Pharma, Honorary Fosun Global Partner
Zhigang Tian
Professor & Director，Institute of Immunology, School of Life Sciences and Medicine
University of Science & Technology of China
Tian Xu
Chief Scientific Advisor
Fosun Pharma
President
Fosun Lead
Vice President
Westlake University
Linyu Shi
Co-Founder & CSO
HuidaGene Therapeutics
Gong Chen
Founder
NeuExcell Therapeutics
Professor, Director of Brain Repair Center
GHM Institute of CNS Regeneration, Jinan University
Lyu Lulu
Chief Executive Officer
Juventas Cell Therapy
Chenxi Ouyang
Director Surgeon
Beijing Fuwai Hospital
Chun Zhang
Founder
Suzhou Genehealth Biotechnology
Yanjun Zhang
R&D Director
Genmedicn Biopharma
Xiao Xiao
Chairman and CSO
Belief Biomed
Lei Yu
Founder
Shanghai Unicar-Therapy Bio-Medicine Technology
Yuxuan Wu
Founder, Chairman and CEO
Yoltech Therapeutics
James Wang
Chief Technology Officer
Juventas Cell Therapy
Lei Guo
Founder and CSO
BioT Beijing Therapeutics
Yangbing Zhao
Chairman & CSO
UTC Therapeutics
Hongbing Zhang
Vice President, Drug Discovery
Eureka Therapeutics
Wenbo Wang
Founder & CEO
Lealing Biopharma
Penghui Zhou
Founder ＆ CTO
Guangzhou Fineimmune Biotechnology
Yi Li
Chairman and Chief Scientific Officer
TIOC Therapeutics
Yanyan Han
Chief Scientific Officer
HRYZ Biotech
Ting He
Founder and CEO
Imunopharm Technology
Ruina Shi
Vice President
Imunopharm Technology
Shiyou Li
Chief Technology Officer
Tricision Biotherapeutics
Xiaofei Gao
Founder
Westlake Therapeutics
Howard Fang
Chief Development Officer
Alpha Biopharma
Rui Chen
VP of R&D
Hervor Therapeutics
Zhiyuan Li
Director of Functional Biology and Cell Therapy
Biotheus
Grace Zhou
Chairman and CEO
ImmVira Pharma
Chelsie He
Founder and CEO
Suzhou GenAssist
Jingmin Zhou
CEO & Co-Founder
Genemagic Biosciences
Yijie Ma
Senior Director, Head of Business Development - Strategic Partnerships
CANbridge Pharmaceuticals
Ruhong Jiang
CEO
ASC Therapeutics
Xinjun He
Co-Founder and CSO
VesiCURE Therapeutics
Yun Jiang
Executive Vice General Manager
LotusLake BioMedical
Adam Zhao
Chairman
Anlong Bio
Biliang Hu
CSO
Truking Gene
Claire G Zhang
Chief Technology Officer
Gritgen Therapeutics
Bin Li
Yu He Scholar, Distinguished Professor
SJTU
Hanming Wang
Vice President
Binhui Bio
Ji-Ye Wei
Chairman and CSO
ViewGene Therapeutics
Frank Hu
Chairman and CEO
Starna Therapeutics
Ping Ding
Chairman and CEO
Cunde
Huashun Li
Chairman
Ascle Therapeutics
Peter He
Co-Founder and CTO
OriCell Therapeutics
Xin Lin
Chairman of the Scientific Advisory Board
BriSTAR Immunotech
Xiaoning Guo
Co-Founder and CEO
Bennu Biotherapeutics
Nova Liu
General Manager
Refreshgene Therapeutics
Ke Huang
Chairman and CEO
Genocury
Peggy Lu
Medical Executive President
Lu Daopei Hospital
Jiangtao Ren
Chief Scientific Officer
BioHeng Biotech
Yongzhong Wang
Founder, Chairman and CEO
Accuredit Therapeutics
HUAQIONG SHEN
CEO & Founder
NeuShen Terapeutics
Yi Jin
Chief Executive Officer
GeCell Therapeutics
Weili Zhao
Vice President & Professor of Hematology，First Deputy Director of Shanghai Institute of Hematology
Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine
He Huang
President
The first Affiliated Hospital, School of Medicine, Zhejiang University
Dewan Zeng
Chief Executive Officer
Innoforce Pharmaceuticals
Mingyao Liu
Founder, Chairman and Chief Scientist
BRL Medicine
Tina Xiao
Head of R&D
MagicRNA
Richard Wang
Founder, Chairman and CEO
Neukio Biotherapeutics
Zefeng Wang
Professor
Shanghai Institute for Nutrition and Health, Chinese Academy of Sciences (CAS)
Weiyue Gu
Chairman
Chineo Medical Technology
Lianjun Shen
SVP, Head of R&D
Gracell Biotechnologies
Fenglan Wu
Chief Executive Officer
Gritgen Therapeutics
Dan Li
Senior Medical Director
Novatim Immune Therapeutics
Chaohui Dai
General Manager
Shanghai HyaMab Biotech
Ke Zhang
Chief Scientific Officer
SCG Cell Therapy
Tina Wang
Chief Operating Officer
Lion TCR
Wen Wang
Founder and CEO
Skye Med
Tony Zhang
Chairman of the Board, President
Wuhan Bio-Raid Biotech
Yuchun Gu
Chief Scientist and CEO
Allife Medicine
Hua Liu
Chairman and CSO
Xinghua Bio
Chijian Zuo
Chief Scientific Officer
Suzhou CureMed Biopharma Technology
Yi Feng
Senior Vice President of Medical Affairs
Juventas Cell Therapy
Lin Yang
Founder and CEO
PersonGen BioTherapeutics
Susan Mou
Chief Executive Officer
CorrectSequence Therapeutics
Yan Sun
Co-Founder and Group COO
Shanghai Cell Therapy Group
Yarong Liu
Founder and CEO
Grit Therapeutics
Cecilia Zhang
Chief Scientific Officer
Biosyngen
Crystal Sun
Founder and CEO
Immunofoco
Yu Zhang
CEO
VCANPHARMA
Jim Lu
Co-Founder and Chief Scientific Officer
TriArm Therapeutic
Jimin Gao
Professor
Wenzhou Medical University
Michael Wang
CEO and Founder
CorrGene Biotechnology
Jie Chen
Chief Medical Officer
IASO Biotherapeutics
Alex Chang
Founder
Shanghai YaKe Biotechnology
Changfeng Zhang
Regulatory Affairs Director
Shanghai Pharmaceuticals Holding
Xingwang Xie
Founder & Chief Executive Officer
Corregene Biotechnology
Enxiu Wang
Founder
Nanjing CART Medical
Tianhong Xu
Founder & CEO
Base Therapeutics
Xiaoyun Shang
Chief Executive Officer
Suzhou T-Maximum Bio-tech
John Ng
General Manager of Asia Pacific
Dark Horse Consulting
Zhibo Han
General Manager
Amcellgene Engineering
Yun Zhang
Co-CEO
Wingor Bio-technology
Fangfang Zhu
Founder & CEO
HemaCell Therapeutics
Wenji Dong
Founder and Chairman
Genmedicn Biopharma
Ting Zhang
Chief Executive Officer
Regend
Xiaoyan Dong
President
Genecradle Therapeutics
Zhao Zhu
Co-Founder and CEO
Neuregen Therapeutics
Biao Dong
Co-Founder and Chief Executive Officer
Sichuan Real & Best Biotech
Andrew Lin
Founder & CEO
Lingyi Biotech
Zhijian Cai
Professor
Zhejiang University
Shi Hu
Associate Professor, School of Basic Medicine
Naval Medical University
尹航
清华大学药学院 教授
Journal of Extracellular Vesicle 责任主编
陶勇
眼科主任医师、教授
首都医科大学附属北京朝阳医院
张灏
暨南大学医学院教授
肿瘤精准医学和病理研究所所长
龙钢
病原生物系教授
复旦大学基础医学院
Libo Zhao
Chief Technology Officer
Echo Biotech
Ferran Prat
SVP, Moon Shots Program Executive Committee
MD Anderson Cancer Center
Lili Wang
Research Director, Translational Research and Gene Editing
Research Associate Professor, Department of Medicine
Translational Research, Gene Therapy Program
Perelman School of Medicine, University of Pennsylvania
Huimin Helen Tao
Principal Scientist, Analytical Development
Novartis Gene Therapies
Markus Haindl
Global Head Gene Therapy Technical Development, Pharma Technical Operations Cell and Gene Therapy
Roche
Rolf G. Werner
Professor, Industrial Biotechnology
University of Tubingen
Supporters
Connect via Wechat
Previous Sponsors
Media Partners
ATMP Beijing Forum 2025  |  Telephone: +86 21 5269 8916  |  E-mail: kevin.tan@deliver-consulting.com
©ATMP Beijing Forum 2025- All rights reserved